Premium
Dyspnoea and hyperventilation induced by synthetic progesterone chlorpromadinone acetate for the treatment of prostatic hypertrophy
Author(s) -
Fujii Kazuhiko,
Kohrogi Hirotsugu,
Hirosako Susumu,
Kawano Osamu,
Hirata Naomi,
Goto Eisuke,
Ando Masayuki
Publication year - 2001
Publication title -
respirology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.857
H-Index - 85
eISSN - 1440-1843
pISSN - 1323-7799
DOI - 10.1046/j.1440-1843.2001.00330.x
Subject(s) - medicine , hyperventilation , hypocapnia , hyperplasia , muscle hypertrophy , breathing , anesthesia , urology , acidosis , hypercapnia
We describe a 74‐year‐old patient with dyspnoea and tachypnoea induced by chlorpromadinone acetate, a synthetic progesterone used to treat prostatic hyperplasia. The dyspnoea, tachypnoea and hypocapnia improved after discontinuing the chlorpromadinone acetate. It is important to recognize that synthetic progesterones can cause dyspnoea and hyperventilation.